Slipped Capital Femoral Epiphysis as a Complication of Growth Hormone Therapy
Slipped capital femoral epiphysis (SCFE) is a rare complication of growth hormone (GH) therapy. Here, we report three patients who developed SCFE during GH therapy. The first two patients had hypopituitarism and had started GH therapy at the age of 15 years 6 months and 13 years 9 months, respective...
Main Authors: | Shuo-Yu Wang, Yi-Ching Tung, Wen-Yu Tsai, Yin-Hsiu Chien, Jing-Sheng Lee, Wuh-Liang Hwu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2007-01-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664609603521 |
Similar Items
-
Slipped capital femoral epiphysis: a population-based study
by: Bengt Herngren, et al.
Published: (2017-07-01) -
INCIDENCE AND EPIDEMIOLOGY OF SLIPPED CAPITAL FEMORAL EPIPHYSIS
by: Oskar Zupanc, et al.
Published: (2002-05-01) -
Total hip arthroplasty in patients with slipped capital femoral epiphysis: a systematic analysis of 915 cases
by: Eustathios Kenanidis, et al.
Published: (2021-01-01) -
Slipped capital femoral epiphysis in primary hyperparathyroidism - Case report with literature review
by: Geena Susan George, et al.
Published: (2019-01-01) -
Slipped capital femoral epiphysis: A modern treatment protocol
by: Slavković Nemanja, et al.
Published: (2009-01-01)